Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma.
Rabin EE, Huang J, Kim M, Mozny A, Lauing KL, Penco-Campillo M, Zhai L, Bommi P, Mi X, Power EA, Prabhu VC, Anderson DE, Barton KP, Walunas TL, Schiltz GE, Amidei C, Sanchez-Gomez P, Thakkar JP, Lukas RV, Wainwright DA. Rabin EE, et al. Among authors: sanchez gomez p. Brain Behav Immun Health. 2024 Mar 15;38:100753. doi: 10.1016/j.bbih.2024.100753. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38600951 Free PMC article.
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.
Álvarez-Vázquez A, San-Segundo L, Cerveró-García P, Flores-Hernández R, Ollauri-Ibáñez C, Segura-Collar B, Hubert CG, Morrison G, Pollard SM, Lathia JD, Sánchez-Gómez P, Tabernero A. Álvarez-Vázquez A, et al. Among authors: sanchez gomez p. Neuro Oncol. 2024 Mar 20:noae060. doi: 10.1093/neuonc/noae060. Online ahead of print. Neuro Oncol. 2024. PMID: 38507464
On optimal temozolomide scheduling for slowly growing glioblastomas.
Segura-Collar B, Jiménez-Sánchez J, Gargini R, Dragoj M, Sepúlveda-Sánchez JM, Pešić M, Ramírez MA, Ayala-Hernández LE, Sánchez-Gómez P, Pérez-García VM. Segura-Collar B, et al. Among authors: sanchez gomez p. Neurooncol Adv. 2022 Sep 27;4(1):vdac155. doi: 10.1093/noajnl/vdac155. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36325374 Free PMC article.
Suppressor of fused associates with dissemination patterns in patients with glioma.
Peris-Celda M, Carrión-Navarro J, Palacín-Aliana I, Sánchez-Gómez P, Acín RP, Garcia-Romero N, Ayuso-Sacido A. Peris-Celda M, et al. Among authors: sanchez gomez p. Front Oncol. 2022 Aug 24;12:923681. doi: 10.3389/fonc.2022.923681. eCollection 2022. Front Oncol. 2022. PMID: 36091108 Free PMC article.
IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas.
Gargini R, Segura-Collar B, Garranzo-Asensio M, Hortigüela R, Iglesias-Hernández P, Lobato-Alonso D, Moreno-Raja M, Esteban-Martin S, Sepúlveda-Sánchez JM, Nevola L, Sánchez-Gómez P. Gargini R, et al. Among authors: sanchez gomez p. Neurotherapeutics. 2022 Jan;19(1):408-420. doi: 10.1007/s13311-021-01176-6. Epub 2022 Jan 31. Neurotherapeutics. 2022. PMID: 35099769 Free PMC article.
52 results